| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Dez―31 |
Solid-Phase Synthesis and Immunological Evaluation of Peptide Conjugates Containing Stereochemically Defined UPam-Based TLR2 Ligands and Epitopes from SARS-CoV-2 Virus |
Giulia Castello, Marjolein M.E. Isendoorn, Marcel Camps, Nico J. Meeuwenoord, Vincent F. H. Verhoeks, Thomas C. van den Ende, Jeroen D. C. Codée, Ferry Ossendorp, Dmitri V. Filippov |
| 2 |
[GO] |
2025―Dez―25 |
A Dual-Targeted, Long-Circulating, and Intelligent-Responsive Antiviral Agent Suppresses SARS-CoV-2 by Blocking Viral Entry and Replication |
Jingyang Zhao, Peng Ye, Huatai Zhu, Yucheng Li, Jiandu Lei |
| 3 |
[GO] |
2025―Jul―16 |
Probing SARS-CoV-2 G-Quadruplexes in the Nsp3 Gene Segment by Fluorescence and 19F NMR Using a Functionalized Nucleoside Analog |
Sarupa Roy, Seergazhi G. Srivatsan |
| 4 |
[GO] |
2025―Feb―24 |
Gag HIV-1 Virus-like Particles and Extracellular Vesicles Functionalization with Spike Epitopes of SARS-CoV-2 Using a Copper-Free Click Chemistry Approach |
Marc García-Trujillo, Jesús Lavado-García, Arnau Boix-Besora, Francesc Gòdia, Laura Cervera |
| 5 |
[GO] |
2021―Nov―14 |
Site-Specific and Stable Conjugation of the SARS-CoV-2 Receptor-Binding Domain to Liposomes in the Absence of Any Other Adjuvants Elicits Potent Neutralizing Antibodies in BALB/c Mice |
Wei-Yun Wholey, Sekou-Tidiane Yoda, Wei Cheng |
| 6 |
[GO] |
2021―Sep―09 |
Correction to “Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys” |
Heng Li, Lei Guo, Huiwen Zheng, Jing Li, Xin Zhao, Jiaqi Li, Yan Liang, Fengmei Yang, Yurong Zhao, Jinling Yang, Mengyi Xue, Yuanyuan Zuo, Jian Zhou, Yanli Chen, Zening Yang, Yanyan Li, Weihua Jin, Haijing Shi, Zhanlong He, Qihan Li, Longding Liu |
| 7 |
[GO] |
2021―Jun―28 |
SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics |
Ivan M. Ryzhov, Alexander B. Tuzikov, Alexey V. Nizovtsev, Ludmila K. Baidakova, Oxana E. Galanina, Nadezhda V. Shilova, Marina M. Ziganshina, Nataliya V. Dolgushina, Guldana R. Bayramova, Gennady T. Sukhikh, Eleanor C. Williams, Radhika Nagappan, Stephen M. Henry, Nicolai V. Bovin |
| 8 |
[GO] |
2021―Mai―06 |
Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys |
Heng Li, Lei Guo, Huiwen Zheng, Jing Li, Xin Zhao, Jiaqi Li, Yan Liang, Fengmei Yang, Yurong Zhao, Jinling Yang, Mengyi Xue, Yuanyuan Zuo, Jian Zhou, Yanli Chen, Zening Yang, Yanyan Li, Weihua Jin, Haijing Shi, Zhanlong He, Qihan Li, Longding Liu |
| 9 |
[GO] |
2020―Dez―24 |
Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2 |
Ross C. Larue, Enming Xing, Adam D. Kenney, Yuexiu Zhang, Jasmine A. Tuazon, Jianrong Li, Jacob S. Yount, Pui-Kai Li, Amit Sharma |
| 10 |
[GO] |
2020―Okt―18 |
Gold/Silver Hybrid Nanoparticles with Enduring Inhibition of Coronavirus Multiplication through Multisite Mechanisms |
Ting Du, Jinyu Zhang, Chunqiao Li, Tao Song, Ping Li, Jifeng Liu, Xinjun Du, Shuo Wang |
| 11 |
[GO] |
2020―Jul―17 |
Comprehensive Review on Current Interventions, Diagnostic, and Nanotechnology Perspectives against SARS-CoV-2 |
Deepak S. Chauhan, Rajendra Prasad, Rohit Srivastava, Meena Jaggi, Subhash C. Chauhan, Murali M. Yallapu |
| 12 |
[GO] |
2020―Jul―08 |
The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis |
Edouard Alphandéry |
|
